NCT07092514 2026-03-17Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)Washington University School of MedicinePhase 2 Recruiting34 enrolled